SCOTTSBLUFF, Neb., – Cancer survivors and the general public are all invited to hear about new clinical trial opportunities now available at Regional West Medical Center.

The Missouri Valley Cancer Consortium will present special speakers Mary Beth Wilwerding and Erin Smith on Tuesday, April 29 at 7 p.m. at the Harms Advanced Technology Center in Scottsbluff to discuss clinical cancer trials. The presentation is free to the public.

Through a partnership with Nebraska hospitals and cancer centers, the Missouri Valley Cancer Consortium is offering opportunities to participate in clinical trials that previously could not be offered locally. This program is an exciting new way for local cancer programs and cancer survivors to participate in cancer research projects.

Founded in 1993, the Missouri Valley Cancer Consortium (MVCC) is a non-profit organization based in Omaha, Nebraska that receives federal funding designed to bring state-of-the-art cancer clinical trials to Omaha and Lincoln metropolitan and surrounding areas.

Plan to attend to learn more about how clinical trials can benefit all patients affected by cancer. For more information, please contact Carol Slafter Diffendaffer, PMHP, PMSW, OSW-C at 308-630-1535 or email: diffenc@rwmc.net.

Regional West Health Services, Scottsbluff, Neb., is the parent company for Regional West Medical Center and Regional West Physicians Clinic. These organizations, with over 1,800 employees, provide comprehensive and innovative health care services for the people and communities of western Nebraska and the neighboring states of Colorado, South Dakota and Wyoming. With over 110 active physicians, 95 percent of whom are board certified or board eligible, plus an additional 25 consulting specialists, the Regional West family of health care organizations offers care that spans more than 30 medical specialties.